Bioactivity improvement of poly(ε-caprolactone) membrane with the addition of nanofibrous bioactive glass
Source abstract
Abstract
Nanofibrous glass with a bioactive composition was added to a degradable polymer poly(epsilon-caprolactone) (PCL) to produce a nanocomposite in thin membrane form ( approximately 260 microm). The bioactivity and osteoblastic responses of the nanocomposite membrane were examined and compared with those of a pure PCL membrane. Glass nanofibers with diameters in the range of hundreds of nanometers were added to a PCL solution at 20 wt.%, and the mixture was stirred vigorously and air dried. The obtained nanocomposite membrane showed that many chopped glass nanofibers formed by the mixing step were embedded uniformly into the PCL matrix. The nanocomposite membrane induced the rapid formation of apatite-like minerals on the surface when immersed in a simulated body fluid. Murine-derived osteoblastic cells (MC3T3-E1) grew actively over the nanocomposite membrane with cell viability significantly improved compared with those on the pure PCL membrane. Moreover, the osteoblastic activity, as assessed by the expression of alkaline phosphatase, was significantly higher on the nanocomposite membrane than on the pure PCL membrane. The currently developed nanocomposite of the bioactive glass-added PCL might find applications in the bone regeneration areas such as the guided bone regeneration (GBR) membrane.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Bioceramics: from concept to clinic10.1111/j.1151-2916.1998.tb02540.x ↗
2. Third-generation biomedical materials10.1126/science.1067404 ↗
3. Biological and medical significance of calcium phosphates10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1 ↗
4. Bioactive glasses: clinical applications
5. Bioactive glass ceramics: properties and applications10.1016/0142-9612(91)90194-F ↗
6. The science and engineering of polymer composite degradation
7. Biodegradable polymers
8. Degradable implant materials: a review of synthetic absorbable polymers and their applications10.1016/S0267-6605(86)80015-4 ↗
9. Biodegradable polymers
10. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products10.1002/jab.770050208 ↗
11. Development of hydroxyapatite bone scaffold for controlled drug release via poly(ε-caprolactone) and hydroxyapatite hybrid coatings10.1002/jbm.b.30038 ↗
12. In vivo investigations on composites made of resorbable ceramics and poly(lactide) used as bone graft substitutes10.1002/jbm.10024 ↗
13. Technique to control pH in vicinity of biodegrading PLA–PGA implants10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U ↗
14. Porous poly(l-lactide)/apatite composites created by biomimetic process10.1002/(SICI)1097-4636(19990615)45:4<285::AID-JBM2>3.0.CO;2-2 ↗
15. Development of guided bone regeneration membrane composed of β-tricalcium phosphate and poly(l-lactide–co-glycolide–co-ε-caprolactone) composites10.1016/j.biomaterials.2004.02.001 ↗
16. Effect of blending calcium compounds on hydrolytic degradation of poly(dl-lactide-acid–co-glycolic-acid)10.1016/S0142-9612(01)00382-9 ↗
17. Bioactivity in in situ hydroxyapatite–polycaprolactone composites10.1002/jbm.a.30774 ↗
18. Effect of fluoridation of hydroxyapatite in hydroxyapatite–polycaprolactone composites on osteoblast activity10.1016/j.biomaterials.2004.11.008 ↗
19. Evaluations of bioactivity and mechanical properties of poly(ε-caprolactone)/silica nanocomposite following heat treatment10.1002/jbm.a.20038 ↗
20. Polycaprolactone/glass bioabsorbable implant in a rabbit humerus fracture model10.1002/(SICI)1097-4636(19970915)36:4<536::AID-JBM12>3.0.CO;2-8 ↗
21. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro10.1002/jbm.a.10399 ↗
22. The effect of bioactive glass content on synthesis and bioactivity of composite poly(lactic–co-glycolic acid)/bioactive glass substrate for tissue engineering10.1016/j.biomaterials.2004.06.027 ↗
23. In vitro evaluation of novel bioactive composites based on Bioglass®-filled polylactide foams for bone tissue engineering scaffolds10.1002/jbm.a.20055 ↗
24. Porous polymer/bioactive glass composites for soft-to-hard tissue interfaces10.1002/jbm.10227 ↗
25. Calcium phosphate formation and ion dissolution rates in silica gel–PDLLA composites10.1016/S0142-9612(03)00425-3 ↗
26. Solution-mediated effect of bioactive glass in poly(lactic–co-glycolic acid)-bioactive glass composites on osteogenesis of marrow stromal cells10.1002/jbm.a.30494 ↗
27. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin like growth factor II mRNA expression and protein syntheses10.1006/bbrc.2000.3503 ↗
28. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D ↗
29. Effects of 58S sol–gel glasses on the temporal expression of bone markers during mouse osteoblastic differentiation10.1002/jbm.a.30637 ↗
30. Degradation and drug release of phosphate-glass/polycaprolactone biological composites for hard tissue regenerative10.1002/jbm.b.30223 ↗
31. Production and potential of bioactive glass nanofiber as a next generation biomaterial10.1002/adfm.200500750 ↗
32. Bioactive glass nanofiber–collagen nanocomposite as a novel bone regeneration matrix10.1002/jbm.a.30848 ↗
33. Poly ε-caprolactone and its copolymers